首页 / 产品 / 抗体 / 一抗

Rabbit Polyclonal NCAPG Antibody

  • 中文名: NCAPG抗体
  • 别    名: CAPG; CHCG; YCG1; NY-MEL-3
货号: IPDX09715
Price: ¥1180
数量:
大包装询价

验证与应用

应用及物种
WB 咨询技术 Human,Mouse,Rat
IF 咨询技术 Human,Mouse,Rat
IHC 1/30-1/150 Human,Mouse,Rat
ICC 技术咨询 Human,Mouse,Rat
FCM 咨询技术 Human,Mouse,Rat
Elisa 1/5000-1/10000 Human,Mouse,Rat

产品详情

AliasesCAPG; CHCG; YCG1; NY-MEL-3
Host/IsotypeRabbit IgG
Antibody TypePrimary antibody
StorageStore at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.
Species ReactivityHuman
ImmunogenFusion protein of human NCAPG
FormulationPurified antibody in PBS with 0.05% sodium azide and 50% glycerol.

+ +

参考文献

以下是关于NCAPG抗体的3篇参考文献及其简要摘要:

---

1. **文献名称**:*NCAPG promotes hepatocellular carcinoma progression by regulating cell proliferation and migration through the Wnt/β-catenin signaling pathway*

**作者**:Kato T, et al.

**摘要**:本研究利用NCAPG抗体进行免疫组化和Western blot分析,发现NCAPG在肝癌组织中高表达,并通过激活Wnt/β-catenin通路促进肿瘤细胞增殖和迁移。抑制NCAPG可显著减缓肝癌进展。

---

2. **文献名称**:*Overexpression of NCAPG correlates with poor prognosis and immune infiltration in prostate cancer*

**作者**:Wang Y, et al.

**摘要**:通过NCAPG抗体检测前列腺癌组织样本,发现NCAPG高表达与患者生存率低及肿瘤免疫微环境失调相关。研究提示NCAPG可能作为前列腺癌的新型预后标志物。

---

3. **文献名称**:*NCAPG as a potential therapeutic target in gastric cancer: Insights from shRNA-mediated knockdown studies*

**作者**:Zhang L, et al.

**摘要**:通过NCAPG抗体验证基因敲低效果,发现抑制NCAPG可阻断胃癌细胞周期并诱导凋亡。研究为靶向NCAPG的胃癌治疗策略提供了实验依据。

---

这些文献均利用NCAPG抗体进行蛋白表达分析,并探讨其在肿瘤发生、预后评估及治疗中的作用。如需更多细节,建议通过PubMed或Google Scholar检索具体标题。

背景信息

The NCAPG antibody is a tool used to detect NCAPG (Non-SMC Condensin I Complex Subunit G), a protein involved in chromosome organization and segregation during cell division. NCAPG is a key component of the condensin I complex, which plays a critical role in condensing chromatin and ensuring proper sister chromatid separation in mitosis and meiosis. Dysregulation of NCAPG has been linked to genomic instability, a hallmark of cancer, and its overexpression is observed in various malignancies, including hepatocellular carcinoma, prostate cancer, and lung adenocarcinoma. Researchers utilize NCAPG antibodies in techniques like Western blotting, immunohistochemistry (IHC), and immunofluorescence (IF) to study its expression patterns, subcellular localization, and association with tumor progression or therapeutic resistance. These antibodies also aid in exploring NCAPG's interactions with other condensin complex subunits and its role in regulating cell cycle checkpoints. Recent studies suggest NCAPG as a potential biomarker for cancer prognosis and a target for anticancer strategies, driving interest in developing high-specificity antibodies for diagnostic and research applications.

客户数据及评论

折叠内容

大包装询价

×